Fertility testing company Proov announced Tuesday that it has raised $9.7 million in Series A funding.
The round was led by Hambrecht Ducera Growth Ventures with participation from SteelSky Ventures, WCC Partners, LightShip Capital, GingerBread Capital and Portfolia.
WHAT THEY DO
In early 2020, Proov scored FDA clearance for its at-home urine test measuring pregnanediol glucuronide, which can...
Inito has announced the launch of its at-home fertility test in the US, months after receiving US FDA approval.
WHAT IT'S FOR
The company claims that Inito is the only ovulation test that measures estrogen and luteinising hormone levels to predict fertile days, as well as progesterone to confirm if ovulation has actually occurred.
The device can also be paired with a smartphone app to provide...
